Science Corporation implants its vision-restoring chip in its first Stargardt disease patient

Stargardt disease kills the eye's light-sensing cells while the inner retina that signals the brain survives. Science Corporation's PRIMA is a two-millimeter chip placed at the back of the eye that acts like artificial photoreceptors, receiving images from camera-equipped glasses. The first Stargardt patient received it in a trial in Australia and later read a word in rehabilitation.

Summary written with AI by HowTechMoves, based on reporting by TechCrunch.